The level of risk, effects response to potential health emergencies, prevention and control method of COVID-19: A systematic review.

Q3 Medicine Human Antibodies Pub Date : 2021-01-01 DOI:10.3233/HAB-200421

Addis Adera Gebru, Tadesse Birhanu, Eshetu Wendimu, Agumas Fentahun Ayalew, Selamawit Mulat, Hussen Zakir Abasimel, Ali Kazemi, Bosenu Abera Tadesse, Beniam Adera Gebru, Berhanu Senbeta Deriba, Nigus Shimelis Zeleke, Abebe Gule Girma, Bulgantsetseg Munkhbat, Qamar Kassim Yusuf, Amana Ogeto Luke, Dejene Hailu

{"title":"The level of risk, effects response to potential health emergencies, prevention and control method of COVID-19: A systematic review.","authors":"Addis Adera Gebru, Tadesse Birhanu, Eshetu Wendimu, Agumas Fentahun Ayalew, Selamawit Mulat, Hussen Zakir Abasimel, Ali Kazemi, Bosenu Abera Tadesse, Beniam Adera Gebru, Berhanu Senbeta Deriba, Nigus Shimelis Zeleke, Abebe Gule Girma, Bulgantsetseg Munkhbat, Qamar Kassim Yusuf, Amana Ogeto Luke, Dejene Hailu","doi":"10.3233/HAB-200421","DOIUrl":null,"url":null,"abstract":"Background: COVID-19 is currently the major public health burden in the world, with disease and death in the global community from COVID-19 increasing rapidly from time to time worldwide. However, there has been a lack of well-organized information about the level of risk, effects, prevention and control methods of the disease. Therefore the aim of this study is to identify and review a published level of risk, effects response to potential health emergencies, prevention, and control methods of COVID-19 at a global level.Method: A systematic review was performed after literatures were identified by searching the following online databases: medRxiv, Google scholar, PubMed, MEDLINE, EMBASE, and the Cochrane Library with supplementary hand searching of conferences. The online databases contain archives of most English biomedical journals. Scientific papers published online by the Center for Disease Control and the World Health Organization were also included for this analysis. The scientific publications from 01 December, 2019 to 13 April 2020 were included. The 'COVID-19', '2019 novel coronavirus', '2019-nCoV', 'novel coronavirus', and 'Pneumonia' key search terms were used for this review.","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":"29 2","pages":"149-169"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/HAB-200421","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Antibodies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/HAB-200421","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Background: COVID-19 is currently the major public health burden in the world, with disease and death in the global community from COVID-19 increasing rapidly from time to time worldwide. However, there has been a lack of well-organized information about the level of risk, effects, prevention and control methods of the disease. Therefore the aim of this study is to identify and review a published level of risk, effects response to potential health emergencies, prevention, and control methods of COVID-19 at a global level.

Method: A systematic review was performed after literatures were identified by searching the following online databases: medRxiv, Google scholar, PubMed, MEDLINE, EMBASE, and the Cochrane Library with supplementary hand searching of conferences. The online databases contain archives of most English biomedical journals. Scientific papers published online by the Center for Disease Control and the World Health Organization were also included for this analysis. The scientific publications from 01 December, 2019 to 13 April 2020 were included. The 'COVID-19', '2019 novel coronavirus', '2019-nCoV', 'novel coronavirus', and 'Pneumonia' key search terms were used for this review.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

2019冠状病毒病风险水平、潜在突发卫生事件应对效果、防控方法综述

背景:COVID-19是目前世界上主要的公共卫生负担，全球范围内因COVID-19引起的疾病和死亡人数不时迅速增加。然而，缺乏关于该疾病的风险程度、影响、预防和控制方法的组织良好的信息。因此，本研究的目的是在全球范围内确定和审查已公布的COVID-19风险水平、对潜在卫生突发事件的影响响应以及预防和控制方法。方法:通过检索medRxiv、Google scholar、PubMed、MEDLINE、EMBASE和Cochrane Library等在线数据库，并辅以手工检索会议，对文献进行系统评价。在线数据库包含大多数英文生物医学期刊的档案。疾病控制中心和世界卫生组织在网上发表的科学论文也被纳入了这项分析。纳入了2019年12月1日至2020年4月13日的科学出版物。“COVID-19”、“2019新型冠状病毒”、“2019- ncov”、“新型冠状病毒”和“肺炎”关键搜索词被用于本综述。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Human Antibodies Medicine-Immunology and Allergy

CiteScore

3.50

自引率

0.00%

发文量

期刊介绍： Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology under a single, cohesive theme. This includes fundamental research, applied science and clinical applications. Emphasis in the published articles is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization, defined antigens, tissue reactivity, scale-up production, chimeric antibodies, autoimmunity, natural antibodies/immune response, anti-idiotypes, and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, will also be featured.